Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 14/20 | 0.77 |
| ▸ | KMT2A | Q03164 | 14/20 | 0.77 |
| ▸ | CYP3A4 | P08684 | 11/20 | 0.77 |
| ▸ | MAPT | P10636 | 8/20 | 0.77 |
| ▸ | CYP2C9 | P11712 | 7/20 | 0.77 |
| ▸ | ABCB1 | P08183 | 7/20 | 0.77 |
| ▸ | CYP2D6 | P10635 | 6/20 | 0.77 |
| ▸ | CYP2C19 | P33261 | 6/20 | 0.77 |
| ▸ | CYP1B1 | Q16678 | 5/20 | 0.77 |
| ▸ | CYP1A2 | P05177 | 5/20 | 0.77 |
| ▸ | FTO | Q9C0B1 | 5/20 | 0.77 |
| ▸ | CYP1A1 | P04798 | 4/20 | 0.77 |
| ▸ | BCHE | P06276 | 4/20 | 0.77 |
| ▸ | ACHE | P22303 | 4/20 | 0.77 |
| ▸ | XDH | P47989 | 4/20 | 0.77 |
| ▸ | CA12 | O43570 | 4/20 | 0.77 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.77 |
| ▸ | MAOA | P21397 | 3/20 | 0.77 |
| ▸ | PPARG | P37231 | 3/20 | 0.77 |
| ▸ | CA7 | P43166 | 3/20 | 0.77 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Galangin SCHEMBL7926038 | 0.95 | MEN1 (0.85) | MEN1KMT2ACYP3A4MAPTCYP2C9 | |
| Kaempferol SCHEMBL31164054 | 0.92 | MEN1 (0.79) | MEN1KMT2ACYP3A4MAPTCYP2C9 | |
| Kaempferol SCHEMBL1485787 | 0.92 | MEN1 (0.79) | MEN1KMT2ACYP3A4MAPTCYP2C9 | |
| Quercetin SCHEMBL111510 | 0.91 | MEN1 (0.76) | MEN1KMT2ACYP3A4MAPTCYP2C9 | |
| Datiscetin SCHEMBL15675904 | 0.90 | MEN1 (0.75) | MEN1KMT2ACYP3A4MAPTCYP2C9 | |
| Morin SCHEMBL2118429 | 0.90 | MEN1 (0.75) | MEN1KMT2ACYP3A4MAPTCYP2C9 | |
| Galangin SCHEMBL117225 | 0.88 | MEN1 (1.00) | MEN1KMT2ACYP3A4MAPTCYP2C9 | |
| Galangin SCHEMBL29393121 | 0.88 | MEN1 (1.00) | MEN1KMT2ACYP3A4MAPTCYP2C9 | |
| Kaempferide SCHEMBL19097707 | 0.86 | ABCB1 (0.79) | MEN1KMT2ACYP3A4MAPTCYP2C9 | |
| Myricetin SCHEMBL19302 | 0.85 | MEN1 (1.00) | MEN1KMT2ACYP3A4MAPTCYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115636859-A | Method for simultaneously separating and purifying two galloylated myricitrin from waxberry leaves and application | 浙江大学 | 2023-01-24 | — | — | CN | claimed |
| CN-116390645-A | Grape rich in phenol | 以色列农业和农村发展部农业研究组织(范卡尼中心) | 2023-07-04 | — | — | CN | disclosed |
| CN-110261499-B | Method for detecting chemical components in polygonum aviculare based on UPLC-Q-TOF/MS | 江阴天江药业有限公司 | 2022-02-11 | — | — | CN | disclosed |
| US-20210333257-A1 | METHODS AND COMPOSITIONS INVOLVING FLAVONOLS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2021-10-28 | — | — | US | disclosed |
| US-20210317497-A1 | MONBRETIN A (MBA) SYNTHESIS USING A HETEROLOGOUS NUCLEIC ACID(S) ENCODING A MBA PATHWAY ENZYME | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2021-10-14 | — | — | US | disclosed |
| WO-2020041310-A1 | METHODS AND COMPOSITIONS INVOLVING FLAVONOLS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2020-02-27 | — | — | WO | disclosed |
| WO-2019241895-A1 | MONBRETIN A (MBA) SYNTHESIS USING A HETEROLOGOUS NUCLEIC ACID(S) ENCODING A MBA PATHWAY ENZYME | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2019-12-26 | — | — | WO | disclosed |
| CN-110261499-A | A method of based on chemical component in UPLC-Q-TOF/MS Jian Ce pivot storage | 江阴天江药业有限公司 | 2019-09-20 | — | — | CN | disclosed |
| CN-104507454-A | Hair colouring compositions comprising gossypetin | UNILEVER NV | 2015-04-08 | — | — | CN | disclosed |
| EP-2209794-B1 | ALPHA-AMYLASE INHIBITORS: THE MONTBRETINS AND USES THEREOF | UNIV BRITISH COLUMBIA (CA) | 2014-12-10 | — | — | EP | disclosed |
| CN-103221056-A | Electronically Modified Reaction Intermediates | MARKOU DEMETRIOS | 2013-07-24 | — | — | CN | disclosed |
| US-8431541-B2 | Alpha-amylase inhibitors: the montbretins and uses thereof | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2013-04-30 | — | — | US | disclosed |
| US-20110189107-A1 | ALPHA-AMYLASE INHIBITORS: THE MONTBRETINS AND USES THEREOF | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2011-08-04 | — | — | US | disclosed |
| EP-2209794-A1 | ALPHA-AMYLASE INHIBITORS: THE MONTBRETINS AND USES THEREOF | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2010-07-28 | — | — | EP | disclosed |
| US-20100075385-A1 | O-Methyltransferases of Tetrahydrobenzylisoquinoline Alkaloid Biosynthesis in Papaver Somniferum | DONALD DANFORTH PLANT SCIENCE CENTER (US) | 2010-03-25 | — | — | US | disclosed |
| WO-2009049428-A1 | ALPHA-AMYLASE INHIBITORS: THE MONTBRETINS AND USES THEREOF | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2009-04-23 | — | — | WO | disclosed |
| US-7514251-B2 | O-methyltransferases of tetrahydrobenzylisoquinoline alkaloid biosynthesis in Papaver somniferum | DONALD DANFORTH PLANT SCIENCE CENTER (US) | 2009-04-07 | — | — | US | disclosed |
| US-20050106588-A1 | O-methyltransferases of tetrahydrobenzylisoquinoline alkaloid biosynthesis in Papaver somniferum | DONALD DANFORTH PLANT SCIENCE CENTER | 2005-05-19 | — | — | US | disclosed |
| WO-2005021763-A2 | O-METHYLTRANSFERASES OF TETRAHYDROBENZYLISOQUINOLINE ALKALOID BIOSYNTHESIS IN PAPAVER SOMNIFERUM | JOHNSON & JOHNSON RESEARCH PTY LTD (AU) | 2005-03-10 | — | — | WO | disclosed |
| EP-1512748-A1 | O-methyltransferases of tetrahydrobenzylisoquinoline alkaloid biosynthesis in papaver somniferum | Johnson & Johnson Research Pty Limited (AU) | 2005-03-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110189107-A1 | ALPHA-AMYLASE INHIBITORS: THE MONTBRETINS AND USES THEREOF | AMY1A, AMY2A, GBA3 | MEN1 2138/4885KMT2A 2548/4885CYP3A4 1380/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.